Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
暂无分享,去创建一个
S. Kannan | V. Nair | V. G. Manasa | M. Sinto | K. Jayasree | F. James | V.G. Manasa | M.S. Sinto | V. Manasa | V.G. Manasa
[1] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[2] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[3] Frank J. Slack,et al. The Role of MicroRNAs in Cancer , 2006, The Yale journal of biology and medicine.
[4] Sin Hang Lee,et al. Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories , 2007, Infectious Agents and Cancer.
[5] Reuven Agami,et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. , 2008, Cancer research.
[6] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[7] Eran Halperin,et al. miRNAkey: a software for microRNA deep sequencing analysis , 2010, Bioinform..
[8] W. Filipowicz,et al. The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.
[9] R. Bhargava,et al. MicroRNA analysis in human papillomavirus (HPV)-associated cervical neoplasia and cancer , 2010, Infectious Agents and Cancer.
[10] Jiarui Li,et al. MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer , 2012, International journal of molecular sciences.
[11] K. Kaarthigeyan. Cervical cancer in India and HPV vaccination , 2012, Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology.
[12] Hong Shi,et al. MiR-125b Inhibits Tumor Growth and Promotes Apoptosis of Cervical Cancer Cells by Targeting Phosphoinositide 3-Kinase Catalytic Subunit Delta , 2012, Cellular Physiology and Biochemistry.
[13] F. Luo,et al. Identification of aberrantly expressed miRNAs in rectal cancer. , 2012, Oncology reports.
[14] B. Kaczkowski,et al. Send Orders of Reprints at Bspsaif@emirates.net.ae a Decade of Global Mrna and Mirna Profiling of Hpv-positive Cell Lines and Clinical Specimens , 2022 .
[15] Emmanuel Barillot,et al. ncPRO-seq: a tool for annotation and profiling of ncRNAs in sRNA-seq data , 2012, Bioinform..
[16] Martin Reczko,et al. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows , 2013, Nucleic Acids Res..
[17] Jacques Ferlay,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .
[18] Yingnan Sun,et al. miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma , 2014, Molecular and Cellular Biochemistry.
[19] Ana Kozomara,et al. miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..
[20] Sin Hang Lee,et al. From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice , 2014, Cancers.
[21] Y. Huang,et al. MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1 , 2014, British Journal of Cancer.
[22] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[23] H. An,et al. Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: clinical impact of miR-363-3p. , 2014, Gynecologic oncology.
[24] C. Pérez-Plasencia,et al. Utility of MicroRNAs and siRNAs in Cervical Carcinogenesis , 2015, BioMed research international.
[25] H. Schayek,et al. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma , 2015, Molecular Cancer.
[26] D. Bartel,et al. Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.
[27] W. Hou,et al. Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer. , 2015, International journal of clinical and experimental pathology.
[28] G. Blandino,et al. Oncogenic MicroRNAs: Key Players in Malignant Transformation , 2015, Cancers.
[29] Yuanbo Li,et al. MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway , 2016, Tumor Biology.
[30] T. Lumley,et al. gplots: Various R Programming Tools for Plotting Data , 2015 .
[31] Zhe Wang,et al. miR-136 Modulates TGF-β1-Induced Proliferation Arrest by Targeting PPP2R2A in Keratinocytes , 2015, BioMed research international.
[32] M. Cui,et al. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1. , 2015, International journal of clinical and experimental pathology.
[33] Artemis G. Hatzigeorgiou,et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..
[34] Yun Xiao,et al. miR-429 inhibits migration and invasion of breast cancer cells in vitro , 2014, International journal of oncology.
[35] Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells , 2016, BMC Cancer.
[36] Anushya Muruganujan,et al. PANTHER version 10: expanded protein families and functions, and analysis tools , 2015, Nucleic Acids Res..
[37] F. Nielsen,et al. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer , 2017, British Journal of Cancer.